Coalition urges FTC block to ABBV-AGN deal

|About: AbbVie Inc. (ABBV)|By:, SA News Editor

Consumer groups and unions want the FTC to block AbbVie's (ABBV +0.4%) $63B acquisition of Allergan (AGN), according to a STAT report.

The coalition says the increasingly concentrated nature of the healthcare industry has led to higher prices and fewer choices. Blocking the ABBV-AGN deal would "prevent further harm to consumers."

Subscribe for full text news in your inbox